Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases.
about
An evolving story of angiotensin-II-forming pathways in rodents and humansCooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin IINovel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease.Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate.Biological implications of preformed mast cell mediators.Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodentsChymase-dependent generation of angiotensin II from angiotensin-(1-12) in human atrial tissue.Protein targets of inflammatory serine proteases and cardiovascular disease.Cloning and expression of human colon mast cell carboxypeptidaseMast cell proteases as pharmacological targetsMast cell tryptases and chymases in inflammation and host defense.Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.GPR30 decreases cardiac chymase/angiotensin II by inhibiting local mast cell number.Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.Chymase mediates angiotensin-(1-12) metabolism in normal human hearts.Cardiac angiotensin-(1-12) expression and systemic hypertension in rats expressing the human angiotensinogen genePrimacy of angiotensin converting enzyme in angiotensin-(1-12) metabolism.Angiotensin II and oxidative stress in the failing heartIncreased fibroblast chymase production mediates procollagen autophagic digestion in volume overload.Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.Knocking out angiotensin II in the heart.Update on role of direct renin inhibitor in diabetic kidney disease.The multiple mechanistic faces of a pure volume overload: implications for therapyPathophysiology of Myocardial Infarction.Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.Inflammation and Fibrosis in Polycystic Kidney Disease.Intracrine angiotensin II functions originate from noncanonical pathways in the human heart.The one-two punch: knocking out angiotensin II in the heart.Effect of long-term treatment with urocortin on the activity of somatic angiotensin-converting enzyme in spontaneously hypertensive rats.ACE-dependent and chymase-dependent angiotensin II generation in normal and glucose-stimulated human mesangial cells.Differential expression of the angiotensin-(1-12)/chymase axis in human atrial tissue.Mechanisms of I/R-Induced Endothelium-Dependent Vasodilator Dysfunction.
P2860
Q26830036-D5777265-5BA3-4AAB-88DB-2FCA0BEF9E47Q28592232-1D17A6FC-0C38-468C-9DDF-A5023159BD4CQ30235583-8DB792E6-FACA-4D51-BCA8-988BF9E6CD87Q33554921-26CC62FC-5DD5-4975-B5F9-7B16156D7947Q33744155-C4C5D415-8480-40A7-98DE-623A442A5B31Q33755314-276BD232-DDE8-4B2A-A914-56A3CA0B0398Q34105211-38BB3B1F-82F1-4123-9A61-AFC50E06FC13Q34114355-B95FF8B5-1EC0-4C17-8599-B90BECD14DD2Q34294652-B984163D-DB0A-46E7-A5AE-29823438F2F4Q34475790-70B074EC-97A9-4FF2-800D-82993B811E88Q34627778-EFE69FA3-5EF5-46A9-8DAB-CFF1FEB67715Q35098737-4F385CA5-497F-486A-AAC5-69EEF193CF30Q35186618-29874773-1145-4691-993A-F1B40A0EDB37Q35233098-A244227D-B7C4-44AF-AF26-0083493FBEE4Q36182961-6AD66ACA-6CA6-4B82-94E5-F7A40B7204B7Q36707557-BCBD4FA6-B533-4CE5-B855-BDF9D223DADCQ36902297-F46C1B74-D216-4C86-BDC8-4319EB95D314Q37142740-2F3E7EE0-D6E4-4BB6-BA43-2E918B731A08Q37166953-765962A7-0039-4B9D-9044-4097E2E2FB3EQ37544243-277345B5-95E5-4EED-9129-815030F82798Q37578873-321EA0F5-821C-4CDD-AA84-262656ABB3F7Q37828452-472142E1-5775-4FBA-A41B-679E083B8DFFQ38200133-B066F2A7-C3E2-454D-AA2A-BD08B26DD453Q38208200-B279A76E-8E01-4781-A708-033A9D16826AQ38596702-58A42003-137D-4EF9-8E3C-C41850F2FC3DQ38750210-1D82DADB-4547-4C7C-9C08-D26A385D9B71Q38837265-4C48D913-90D3-40E7-BA81-11B2BEC453ABQ38846247-3B23D286-5DF9-4EB0-BA90-B200D6CE1CC7Q39813086-68E44901-D235-4078-B368-CC6708942EBCQ43125776-F76D6B6F-1ECB-41FC-86C4-B42E182E39F4Q46595582-C8672441-91EA-4A17-B61A-7CDE226E3945Q48080337-C3727C4F-CB43-465D-B28A-C4426189AA6FQ49188523-E3B9827F-AA82-47D5-B146-CE894C2339CC
P2860
Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dissecting the role of chymase ...... art and blood vessel diseases.
@ast
Dissecting the role of chymase ...... art and blood vessel diseases.
@en
Dissecting the role of chymase ...... art and blood vessel diseases.
@nl
type
label
Dissecting the role of chymase ...... art and blood vessel diseases.
@ast
Dissecting the role of chymase ...... art and blood vessel diseases.
@en
Dissecting the role of chymase ...... art and blood vessel diseases.
@nl
prefLabel
Dissecting the role of chymase ...... art and blood vessel diseases.
@ast
Dissecting the role of chymase ...... art and blood vessel diseases.
@en
Dissecting the role of chymase ...... art and blood vessel diseases.
@nl
P1476
Dissecting the role of chymase ...... art and blood vessel diseases.
@en
P2093
Ahsan Husain
Louis J Dell'Italia
P304
P356
10.1097/00001573-200207000-00009
P577
2002-07-01T00:00:00Z